A perspective and framework for developing sample type specific databases for LC/MS-based clinical metabolomics

Nichole A. Reisdorph, Scott Walmsley, Rick Reisdorph

Research output: Contribution to journalArticle

Abstract

Metabolomics has the potential to greatly impact biomedical research in areas such as biomarker discovery and understanding molecular mechanisms of disease. However, compound identification (ID) remains a major challenge in liquid chromatography mass spectrometry-based metabolomics. This is partly due to a lack of specificity in metabolomics databases. Though impressive in depth and breadth, the sheer magnitude of currently available databases is in part what makes them ineffective for many metabolomics studies. While still in pilot phases, our experience suggests that custom-built databases, developed using empirical data from specific sample types, can significantly improve confidence in IDs. While the concept of sample type specific databases (STSDBs) and spectral libraries is not entirely new, inclusion of unique descriptors such as detection frequency and quality scores, can be used to increase confidence in results. These features can be used alone to judge the quality of a database entry, or together to provide filtering capabilities. STSDBs rely on and build upon several available tools for compound ID and are therefore compatible with current compound ID strategies. Overall, STSDBs can potentially result in a new paradigm for translational metabolomics, whereby investigators confidently know the identity of compounds following a simple, single STSDB search.

Original languageEnglish (US)
Article number8
JournalMetabolites
Volume10
Issue number1
DOIs
StatePublished - Jan 2020

Fingerprint

Metabolomics
Databases
Liquid chromatography
Biomarkers
Liquid Chromatography
Libraries
Mass spectrometry
Biomedical Research
Mass Spectrometry
Research Personnel

Keywords

  • Compound identification
  • Database
  • Metabolite identification
  • Metabolomics
  • Spectral library

PubMed: MeSH publication types

  • Journal Article

Cite this

A perspective and framework for developing sample type specific databases for LC/MS-based clinical metabolomics. / Reisdorph, Nichole A.; Walmsley, Scott; Reisdorph, Rick.

In: Metabolites, Vol. 10, No. 1, 8, 01.2020.

Research output: Contribution to journalArticle

@article{f744bc0c3f364ab9a4c3064a0ca7f27b,
title = "A perspective and framework for developing sample type specific databases for LC/MS-based clinical metabolomics",
abstract = "Metabolomics has the potential to greatly impact biomedical research in areas such as biomarker discovery and understanding molecular mechanisms of disease. However, compound identification (ID) remains a major challenge in liquid chromatography mass spectrometry-based metabolomics. This is partly due to a lack of specificity in metabolomics databases. Though impressive in depth and breadth, the sheer magnitude of currently available databases is in part what makes them ineffective for many metabolomics studies. While still in pilot phases, our experience suggests that custom-built databases, developed using empirical data from specific sample types, can significantly improve confidence in IDs. While the concept of sample type specific databases (STSDBs) and spectral libraries is not entirely new, inclusion of unique descriptors such as detection frequency and quality scores, can be used to increase confidence in results. These features can be used alone to judge the quality of a database entry, or together to provide filtering capabilities. STSDBs rely on and build upon several available tools for compound ID and are therefore compatible with current compound ID strategies. Overall, STSDBs can potentially result in a new paradigm for translational metabolomics, whereby investigators confidently know the identity of compounds following a simple, single STSDB search.",
keywords = "Compound identification, Database, Metabolite identification, Metabolomics, Spectral library",
author = "Reisdorph, {Nichole A.} and Scott Walmsley and Rick Reisdorph",
year = "2020",
month = "1",
doi = "10.3390/metabo10010008",
language = "English (US)",
volume = "10",
journal = "Metabolites",
issn = "2218-1989",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - A perspective and framework for developing sample type specific databases for LC/MS-based clinical metabolomics

AU - Reisdorph, Nichole A.

AU - Walmsley, Scott

AU - Reisdorph, Rick

PY - 2020/1

Y1 - 2020/1

N2 - Metabolomics has the potential to greatly impact biomedical research in areas such as biomarker discovery and understanding molecular mechanisms of disease. However, compound identification (ID) remains a major challenge in liquid chromatography mass spectrometry-based metabolomics. This is partly due to a lack of specificity in metabolomics databases. Though impressive in depth and breadth, the sheer magnitude of currently available databases is in part what makes them ineffective for many metabolomics studies. While still in pilot phases, our experience suggests that custom-built databases, developed using empirical data from specific sample types, can significantly improve confidence in IDs. While the concept of sample type specific databases (STSDBs) and spectral libraries is not entirely new, inclusion of unique descriptors such as detection frequency and quality scores, can be used to increase confidence in results. These features can be used alone to judge the quality of a database entry, or together to provide filtering capabilities. STSDBs rely on and build upon several available tools for compound ID and are therefore compatible with current compound ID strategies. Overall, STSDBs can potentially result in a new paradigm for translational metabolomics, whereby investigators confidently know the identity of compounds following a simple, single STSDB search.

AB - Metabolomics has the potential to greatly impact biomedical research in areas such as biomarker discovery and understanding molecular mechanisms of disease. However, compound identification (ID) remains a major challenge in liquid chromatography mass spectrometry-based metabolomics. This is partly due to a lack of specificity in metabolomics databases. Though impressive in depth and breadth, the sheer magnitude of currently available databases is in part what makes them ineffective for many metabolomics studies. While still in pilot phases, our experience suggests that custom-built databases, developed using empirical data from specific sample types, can significantly improve confidence in IDs. While the concept of sample type specific databases (STSDBs) and spectral libraries is not entirely new, inclusion of unique descriptors such as detection frequency and quality scores, can be used to increase confidence in results. These features can be used alone to judge the quality of a database entry, or together to provide filtering capabilities. STSDBs rely on and build upon several available tools for compound ID and are therefore compatible with current compound ID strategies. Overall, STSDBs can potentially result in a new paradigm for translational metabolomics, whereby investigators confidently know the identity of compounds following a simple, single STSDB search.

KW - Compound identification

KW - Database

KW - Metabolite identification

KW - Metabolomics

KW - Spectral library

UR - http://www.scopus.com/inward/record.url?scp=85077527530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077527530&partnerID=8YFLogxK

U2 - 10.3390/metabo10010008

DO - 10.3390/metabo10010008

M3 - Article

C2 - 31877765

AN - SCOPUS:85077527530

VL - 10

JO - Metabolites

JF - Metabolites

SN - 2218-1989

IS - 1

M1 - 8

ER -